Related Experiment Video
Updated: Mar 23, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Regulation of ErbB2 localization and function in breast cancer cells by ERM proteins
Nagham Asp1,2,3, Audun Kvalvaag1,2, Kirsten Sandvig1,2,4
1Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.
Abstract:
The ERM protein family is implicated in processes such as signal transduction, protein trafficking, cell proliferation and migration. Consequently, dysregulation of ERM proteins has been described to correlate with carcinogenesis of different cancer types. However, the underlying mechanisms are poorly understood. Here, we demonstrate a novel functional interaction between ERM proteins and the ErbB2 receptor tyrosine kinase in breast cancer cells. We show that the ERM proteins ezrin and radixin are associated with ErbB2 receptors at the plasma membrane, and depletion or functional inhibition of ERM proteins destabilizes the interaction of ErbB2 with ErbB3, Hsp90 and Ebp50. Accompanied by the dissociation of this protein complex, binding of ErbB2 to the ubiquitin-ligase c-Cbl is increased, and ErbB2 becomes dephosphorylated, ubiquitinated and internalized. Furthermore, signaling via Akt- and Erk-mediated pathways is impaired upon ERM inhibition. Finally, interference with ERM functionality leads to receptor degradation and reduced cellular levels of ErbB2 and ErbB3 receptors in breast cancer cells.
Insights
Ezrin, radixin, and ERM proteins regulate ErbB2 receptor signaling in breast cancer. Inhibiting ERM proteins disrupts ErbB2 interactions, leading to receptor degradation and impaired cancer cell signaling.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The ERM (ezrin, radixin, moesin) protein family plays roles in cell signaling and migration.
- ERM protein dysregulation is linked to various cancers, but mechanisms remain unclear.
- ErbB2 receptor tyrosine kinase is crucial in breast cancer development and progression.
Purpose of the Study:
- To investigate the functional interaction between ERM proteins and ErbB2 in breast cancer.
- To elucidate the role of ERM proteins in regulating ErbB2 receptor stability and signaling.
Main Methods:
- Co-immunoprecipitation assays to detect protein-protein interactions.
- Western blotting to assess protein levels and phosphorylation.
- Depletion and functional inhibition of ERM proteins.
- Analysis of downstream signaling pathways (Akt, Erk).
Main Results:
- ERM proteins ezrin and radixin associate with ErbB2 at the plasma membrane.
- ERM inhibition destabilizes the ErbB2 complex, increasing c-Cbl binding and promoting ErbB2 ubiquitination, dephosphorylation, and internalization.
- ERM inhibition impairs Akt and Erk signaling pathways.
- Interference with ERM proteins leads to degradation of ErbB2 and ErbB3 receptors.
Conclusions:
- ERM proteins are novel regulators of ErbB2 receptor tyrosine kinase in breast cancer.
- ERM proteins are essential for maintaining ErbB2 stability and downstream signaling.
- Targeting ERM proteins may represent a therapeutic strategy for ErbB2-positive breast cancers.
Related Concept Videos
Mitogens and the Cell Cycle
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Master Transcription Regulators
Abnormal Proliferation

